CN112891257A - Mosquito-repellent composition and application thereof - Google Patents

Mosquito-repellent composition and application thereof Download PDF

Info

Publication number
CN112891257A
CN112891257A CN202110109252.8A CN202110109252A CN112891257A CN 112891257 A CN112891257 A CN 112891257A CN 202110109252 A CN202110109252 A CN 202110109252A CN 112891257 A CN112891257 A CN 112891257A
Authority
CN
China
Prior art keywords
mosquito repellent
parts
anophelifuge
weight
mosquito
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110109252.8A
Other languages
Chinese (zh)
Other versions
CN112891257B (en
Inventor
孙金媛
赵崇江
王俊林
陈意平
佘奕河
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Runben Biotechnology Co ltd
Original Assignee
Runben Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Runben Biotechnology Co ltd filed Critical Runben Biotechnology Co ltd
Priority to CN202110109252.8A priority Critical patent/CN112891257B/en
Publication of CN112891257A publication Critical patent/CN112891257A/en
Application granted granted Critical
Publication of CN112891257B publication Critical patent/CN112891257B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a mosquito repellent composition, and belongs to the technical field of daily necessities. The mosquito repellent composition comprises mosquito repellent ester and balsam seed oil. The invention also discloses a mosquito repellent containing the mosquito repellent composition and a preparation method thereof, and the mosquito repellent can enhance the mosquito repellent effect and the itching relieving effect by mutually matching the components; meanwhile, no alcohol is added into the mosquito repellent, and the preparation process is simple; the system is uniform, transparent and clear, and the hydrolysis degree of the anophelifuge ester is low.

Description

Mosquito-repellent composition and application thereof
Technical Field
The invention relates to a mosquito repellent composition and application thereof, and belongs to the technical field of daily necessities.
Background
The mosquito repellent ester is chemically named as acetamido butyl ester, is partially dissolved in water, has high safety, and is commonly used as a mosquito repellent. The products containing the anophelifuge are mainly prepared into sprays, emulsions and the like, and the emulsions are mainly sprays due to the inconvenient use form. The anophelifuge ester has poor water solubility and high degradation rate in water, so most of the anophelifuge spray is wrapped by an alcohol system or a microcapsule.
Patent CN201911412675.6 provides a mosquito repellent ester long-acting repellent, which is composed of the following raw materials by weight: 5-20% of anophelifuge, 5-20% of polyvinylpyrrolidone, 15-40% of absolute ethyl alcohol, 5-20% of polyethylene glycol-4005, 10-30% of alpha-pyrrolidone and the balance of deionized water; aims to solve the problems that the prior mosquito repellent is directly smeared on the surface of skin, wastes time and labor during application and is easy to cause allergy. Patent CN106137780B provides a microcapsule containing anophelifuge ester, anophelifuge water and a preparation method thereof, wherein chitosan and polyglutamic acid are used for wrapping the anophelifuge ester, and the ester is isolated from skin, so that irritation to the skin is reduced, slow release of the anophelifuge agent is realized, and the anophelifuge effect is lasting.
The skin of infants is more fragile than that of adults, the skin is irritated by adding alcohol, the skin is dry and dehydrated after long-term use, and the mosquito repellent product containing alcohol brings the risk of alcohol allergy and is not suitable for long-term use. The microcapsule has larger grain diameter which is in micron level, is easy to generate precipitation for a spraying system with smaller viscosity, is not beneficial to the release of effective components, and simultaneously, the prepared product generally presents milky white and is not beautiful.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide the mosquito repellent composition which does not contain alcohol and has good itching relieving effect and the application thereof.
In order to achieve the purpose, the invention adopts the technical scheme that: a mosquito repellent composition comprises 6-15 parts by weight of anophelifuge and 0.01-3 parts by weight of oleum Olivarum.
The mosquito repellent ester is also called deet and Yimeining, is colorless to light yellow transparent liquid at normal temperature, has no toxic or side effect on skin and mucosa, and has no allergy and permeability; the anophelifuge ester has stable chemical properties, can be used under different climatic conditions, and has long mosquito repelling time. The mosquito repellent ester is used for seeking a target according to the smell given out by a human body, such as exhaled gas and the smell given out by skin, through an olfactory system, and has the function of forming a barrier on the surface of the human body, so that the smell given out by the human body is isolated, the olfactory system of the mosquito is paralyzed, the smell induction of the mosquito is interfered, and the mosquito repellent effect is realized. The bitter oil tree seed oil is relatively viscous oil with fruity flavor, is golden yellow, is rich in various fatty acids, and also contains limonin compounds, sterols and tannins; the oleum Olivarum has effects of relieving itching, calming and detumescence. The anophelifuge ester and the balsam seed oil are compounded, so that the content of the anophelifuge ester is reduced, the synergistic effect is realized, and the mosquito repelling effect is achieved.
As a preferred embodiment of the mosquito repelling composition, the mosquito repelling composition comprises 6 to 10 parts by weight of anophelifuge and 0.01 to 1 part by weight of oleum Olivarum. The anophelifuge ester and the balsam pear seed oil can be better matched with each other in the proportion, and the mosquito repelling effect is better.
As a preferred embodiment of the mosquito repellent composition, the mosquito repellent composition also comprises 0.02-0.1 part by weight of hydroxyphenylpropionamide benzoic acid.
Hydroxyphenylpropionamide benzoic acid, also known as dihydroavenanthramide D, is an active ingredient of oats. The avenanthramides have multifunctional anti-inflammatory activity, including inhibiting the degradation of keratinized nuclear factor NF-kB-alpha directly related to inflammation, and preventing the phosphorylation of p65 protein subunit on the nuclear factor NF-kB, thereby blocking the generation process of cell inflammation; reducing the occurrence of inflammatory immune response and the reaction of neurodermatitis in the skin. The avenanthramides can inhibit the activity of TNF-alpha induced NF-kB degrading enzyme, reduce inflammatory factors and cause the release of IL-8 in atopic dermatitis. At low concentrations of 30ppm, avenanthramides can greatly reduce the number of itching episodes in contact and neurodermatitis. The avenanthramides have potent anti-inflammatory and antipruritic properties and are potent non-steroidal anti-inflammatory antipruritic natural ingredients.
In addition, the invention also provides a mosquito repellent containing the mosquito repellent composition.
As a preferred embodiment of the mosquito repellent, the mosquito repellent comprises the following components in parts by weight: 6-15 parts of anophelifuge, 0.01-3 parts of balsam seed oil, 1-10 parts of main surfactant, 3-20 parts of cosurfactant, 0.02-0.1 part of hydroxyphenylpropionamide benzoic acid, 0.3-1 part of preservative, 0.1-0.3pH value buffer and the balance of water. The mosquito repellent prepared by the formula has good mosquito repelling effect and itching relieving effect.
As a preferred embodiment of the mosquito repellent, the mosquito repellent comprises the following components in parts by weight: 7 parts of anophelifuge, 0.2 part of balsam seed oil, 3 parts of main surfactant, 10 parts of cosurfactant, 0.05 part of hydroxyphenylpropionamide benzoic acid, 0.6 part of preservative, 0.2pH value buffer and the balance of water. When the proportion is adopted, the mosquito repellent has the best mosquito repellent effect and itching relieving effect.
In a preferred embodiment of the mosquito repellent according to the present invention, the primary surfactant is one of sodium cocoamidopropyl PG-dimethyl ammonium chloride phosphate, sodium lauroyl oat amino acid, sodium lauroyl glutamate, sodium lauroyl sarcosinate, sodium cocoyl glutamate, and sodium lauroyl lysine.
Cocamidopropyl-PG-dimethyl ammonium chloride phosphate (natural bionic phospholipid) is a derivative of phospholipid, has good affinity with skin, has a certain repairing function on damaged skin and hair, can supplement phospholipid and grease lost by the skin, and is an extremely mild amphoteric surfactant. Sodium lauroyl oat amino acid, sodium lauroyl glutamate, sodium lauroyl sarcosinate, sodium cocoyl glutamate and sodium lauroyl lysine belong to amino acid surfactants, and the amino acid surfactants not only have good degradability, antibacterial property and safety, but also have no allergy. And due to the special structure, the amphoteric surfactant has many excellent properties of good water solubility, strong salt resistance, pH responsiveness and the like.
In a preferred embodiment of the mosquito repellent according to the present invention, the co-surfactant is at least one of propylene glycol, methyl propylene glycol, butylene glycol, and pentylene glycol.
Propylene glycol is a transparent, colorless, viscous substance, and belongs to a small molecule moisture-retaining component, and can retain water in the stratum corneum. The butanediol is a mild, fresh and cool solution without viscosity, prevents the volatilization of effective components in the mosquito repellent liquid, has no harm to skin after being used, and can also destroy the living environment of bacteria. The pentanediol is an important intermediate of the bactericide propiconazole, and has excellent moisturizing performance and an antiseptic effect.
As a preferred embodiment of the mosquito repellent of the present invention, the preservative is at least one of p-hydroxyacetophenone, hexanediol, caprylyl glycol, and caprylyl hydroxamic acid.
The p-hydroxyacetophenone is mild, free of additive and free of irritant preservative, has the functions of resisting oxidation, tranquilizing and relieving, and has a synergistic effect when being compounded with other preservatives. Hexanediol is a diol, belongs to a rapidly volatile solvent, and is completely soluble in water. And can be used as antibacterial agent with antibacterial effect. The caprylyl glycol is a good humectant, has a bacteriostatic function, is a skin conditioner, can play a role in moisturizing and softening, and achieves the effects of mildness and corrosion prevention. The caprylyl hydroximic acid belongs to coconut oil derivatives, has high-efficiency and selective chelating capacity on ferrous ions and ferric ions, and has limited growth of mould in an environment with limited ferric ions; meanwhile, the optimal carbon chain length capable of promoting the degradation of the cell membrane structure is provided; therefore, has stronger antibacterial ability.
In a third aspect, the invention also provides a preparation method of the mosquito repellent, which comprises the following steps:
(1) adding water and a pH buffering agent into a stirring pot, and adjusting the pH value of the solution to 6.5-7;
(2) adding anophelifuge, oleum Olivarum, major surfactant, co-surfactant, and hydroxyphenylpropionamide benzoic acid into the stirring pot, and stirring to obtain mixture;
(3) and adding the preservative into the mixture and uniformly stirring to obtain the mosquito repellent.
The anophelifuge prepared by the method is transparent and clear, has a uniform system, and has low hydrolysis degree.
The invention has the beneficial effects that: the invention provides a mosquito repellent composition and application thereof, and the mosquito repellent composition can increase the mosquito repellent effect and the itching relieving effect; the mosquito repellent prepared from the mosquito repellent composition has no alcohol, and the preparation process is simple; the mosquito repellent is transparent and clear, has a uniform system and has a good mosquito repellent effect; and the hydrolysis degree of the anophelifuge in the anophelifuge is low.
Detailed Description
To better illustrate the objects, aspects and advantages of the present invention, the present invention will be further described with reference to specific examples.
The compositions of the mosquito repellent composition and the mosquito repellent agent described in examples 1 to 4 and comparative examples 1 to 6 are shown in table 1.
The preparation method of the mosquito repellent disclosed in the embodiment 1-4 and the comparative example 1-6 comprises the following steps:
(1) adding water and a pH buffering agent into a stirring pot, and adjusting the pH value of the solution to 6.5-7;
(2) adding anophelifuge, oleum Olivarum, major surfactant, co-surfactant, and hydroxyphenylpropionamide benzoic acid into the stirring pot, and stirring to obtain mixture;
(3) and adding the preservative into the mixture and uniformly stirring to obtain the mosquito repellent.
TABLE 1
Figure BDA0002916114770000051
Figure BDA0002916114770000061
Example 5
The heat storage stability of the mosquito repellent described in examples 1 to 4 and comparative examples 1 to 6 was measured.
The test method comprises the following steps: placing the mosquito repellent in a constant temperature box at (54 +/-2) DEG for 14 days, taking out, wiping the bottle body, and observing whether the liquid is layered/turbid or has other changes. The test results are shown in table 2.
TABLE 2
Figure BDA0002916114770000071
As can be seen from Table 2, the mosquito repellent of the present invention has good thermal stability without containing alcohol. However, when the surfactant is less than the given range, the stability of the mosquito repellent becomes poor and delamination occurs.
Example 6
The degradation rate of the anophelifuge in the anophelifuge of the examples 1 to 4, the comparative examples 1 to 3 and the comparative example 6 was determined.
The measurement method is as follows:
(1) testing the content of anophelifuge: dissolving the anophelifuge with ethanol, taking n-octadecane as an internal standard substance, and performing gas chromatography separation and determination on the content of anophelifuge in the anophelifuge by using an HP-5 capillary column and a hydrogen flame ionization detector.
(2) And (3) testing the degradation rate: testing the content of anophelifuge in the anophelifuge according to the detection method, placing the anophelifuge in a thermostat at (54 + -2) deg.C for 14 days, taking out, wiping off the bottle, and testing the content of anophelifuge again.
The degradation rate M of the anophelifuge is calculated according to the following formula:
Figure BDA0002916114770000072
m- -anophelifuge degradation rate
WFront side- -anophelifuge content of pre-heat storage sample
WRear end- -repellent ester content of samples after thermal storage
The test results are shown in table 3.
TABLE 3
Figure BDA0002916114770000081
As can be seen from Table 3, the degradation rates of the anophelifuge in the mosquito repellent are all less than 10%, and the mosquito repellent meets the requirements of pesticide registration certificates. When the surfactant is higher than the range given by the invention, the degradation rate of the anophelifuge is more than 10%.
Example 7
The mosquito repellent effects of the mosquito repellents of examples 1 to 4, comparative examples 1 to 3 and comparative example 6 were measured.
The test method comprises the following steps: GB/T13917.9-2009 indoor pesticide effect test and evaluation part 9 of sanitary insecticides for pesticide registration certificate: repellent
The test method comprises the following steps:
attack force test:
300 test insects are put into the mosquito cage, the back of the hand of a tester is exposed to the skin of 40mm multiplied by 40mm, and the rest part is tightly shielded. The hands are put into the mosquito cage for 2min, the mosquitoes are closely observed to stop falling, the arms are shaken to drive the mosquitoes away before the mouth organ of the mosquitoes penetrates into the skin, and the condition is recorded as that 1 test insect stops falling. More than 30 test persons stopping falling in 2min and the test insects are qualified in attack power, and the persons and the mosquitoes in the cage can be subjected to repellent tests.
Repelling test:
selecting 4 testers with qualified offensive power (half of male and female, no need for drinking wine, tea or coffee before and during the test, and no use of essence-containing product), drawing skin area of 50mm × 50mm on the backs of two hands, one of them is pressed to 1.5 μ L/cm2The dosage of the mosquito repellent is uniformly smeared, 40mm multiplied by 40mm of skin is exposed, the rest part is closely shielded, and the other hand is a blank control. When the mosquito repellent is applied for 2h, the hands are put into a mosquito cage filled with mosquitoes with qualified attack power for 2min, and whether the mosquitoes come and stop and suck blood is observed. And then testing every 1h, and judging that the mosquito repellent fails as long as 1 mosquito sucks blood in front. The effective protection time (h) of the mosquito repellent was recorded. The hand is compared and tested first each time, attackThe tested insects with qualified attack force can be tested continuously, and the tested insects with unqualified attack force need to be replaced with qualified tested insects for testing.
The drug effect calculation method comprises the following steps:
the effective protection time of the mosquito repellent on 4 subjects is added, and the average value is taken as the effective protection time of the mosquito repellent. And performing pesticide effect evaluation on the effective protection time of testers according to the mosquito repellent, wherein the effective protection time of the A level is more than or equal to 6.0h, and the effective protection time of the B level is more than or equal to 4.0 h.
The test results are shown in table 4.
TABLE 4
Figure BDA0002916114770000091
As can be seen from Table 4, the mosquito repellent of the present invention has an indoor repelling time of more than 6h and an A-grade drug effect.
Example 8
The irritation of the mosquito repellent to human skin is examined.
The test method is as follows: the subjects were 30 persons in total, with an age of 24 to 59 years, of which 10 men and 20 women. Selecting qualified spot test equipment, placing 0.02-0.025 ml of mosquito repellent into the spot test equipment by a closed spot test method, externally applying hypoallergenic adhesive tape to the back of a subject, removing the subject after 24 hours, observing skin reactions at 0.5, 24 and 48 hours after removal, and recording the results according to the skin reaction grading standard in technical Specification for cosmetic safety (2015 edition), wherein the results are shown in Table 5.
TABLE 5
Figure BDA0002916114770000101
As can be seen from Table 5, the mosquito repellent of the present invention has no skin irritation.
Example 9
The antipruritic effects of the mosquito repellents described in examples 1-4 and comparative examples 1-3 were tested.
The test method is as follows: the mice are randomly divided into 9 groups, the mosquito repellent is smeared on the right hind paw of the mice according to the dose of 10g/kg, and the blank control group is smeared with the same amount of distilled water. After 10min intervals, 0.05mL of histamine phosphate solution with the histamine phosphate mass percent of 0.01% is dripped on the wound surface of each mouse, and 0.05mL of histamine phosphate solution with the histamine phosphate mass percent of 0.01%, 0.02%, 0.03% and 0.04% are dripped at intervals of 3min in sequence, until the mouse licks the right hind paw by returning the head, the total amount of histamine given when the mouse licks the right hind paw by returning the head is taken as an antipruritic threshold, and the test results are shown in Table 6.
TABLE 6
Number of experimental animals Threshold of itching relieving (μ g)
Example 1 4 420.5
Example 2 4 408.7
Example 3 4 415.3
Example 4 4 410.5
Comparative example 1 4 401.3
Comparative example 2 4 390.1
Comparative example 3 4 380.6
Blank control group 4 36.1
As can be seen from Table 6, the mosquito repellent of the present invention has a high threshold of itching relief and a good effect of itching relief.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (10)

1. A mosquito repellent composition is characterized by comprising 6-15 parts by weight of anophelifuge and 0.01-3 parts by weight of oleum Olivarum.
2. A mosquito repellent composition according to claim 1, wherein the composition comprises 6 to 10 parts by weight of anophelifuge ester and 0.01 to 1 part by weight of oleum Olivarum.
3. A mosquito repellent composition according to claim 1, further comprising 0.02 to 0.1 parts by weight of hydroxyphenylpropionamide benzoic acid.
4. A mosquito repellent comprising the mosquito repellent composition of any one of claims 1 to 3.
5. The mosquito repellent according to claim 4, wherein the mosquito repellent comprises the following components in parts by weight: 6-15 parts of anophelifuge, 0.01-3 parts of balsam seed oil, 1-10 parts of main surfactant, 3-20 parts of cosurfactant, 0.02-0.1 part of hydroxyphenylpropionamide benzoic acid, 0.3-1 part of preservative, 0.1-0.3pH value buffer and the balance of water.
6. The mosquito repellent according to claim 5, wherein the mosquito repellent comprises the following components in parts by weight: 7 parts of anophelifuge, 0.2 part of balsam seed oil, 3 parts of main surfactant, 10 parts of cosurfactant, 0.05 part of hydroxyphenylpropionamide benzoic acid, 0.6 part of preservative, 0.2pH value buffer and the balance of water.
7. A mosquito repellent according to claim 5, wherein said primary surfactant is one of sodium cocoamidopropyl PG-dimethyl ammonium chloride phosphate, sodium lauroyl oat amino acid, sodium lauroyl glutamate, sodium lauroyl sarcosinate, sodium cocoyl glutamate and sodium lauroyl lysine.
8. A mosquito repellent according to claim 5, wherein said co-surfactant is at least one of propylene glycol, methyl propylene glycol, butylene glycol, and pentylene glycol.
9. A mosquito repellent according to claim 5, wherein said preservative is at least one of p-hydroxyacetophenone, hexylene glycol, caprylyl glycol, and caprylyl hydroxamic acid.
10. A method of producing a mosquito repellent according to any one of claims 4 to 9, comprising the steps of:
(1) adding water and a pH buffering agent into a stirring pot, and adjusting the pH value of the solution to 6.5-7;
(2) adding anophelifuge, oleum Olivarum, major surfactant, co-surfactant, and hydroxyphenylpropionamide benzoic acid into the stirring pot, and stirring to obtain mixture;
(3) and adding the preservative into the mixture and uniformly stirring to obtain the mosquito repellent.
CN202110109252.8A 2021-01-26 2021-01-26 Mosquito-repellent composition and application thereof Active CN112891257B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110109252.8A CN112891257B (en) 2021-01-26 2021-01-26 Mosquito-repellent composition and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110109252.8A CN112891257B (en) 2021-01-26 2021-01-26 Mosquito-repellent composition and application thereof

Publications (2)

Publication Number Publication Date
CN112891257A true CN112891257A (en) 2021-06-04
CN112891257B CN112891257B (en) 2022-11-15

Family

ID=76120497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110109252.8A Active CN112891257B (en) 2021-01-26 2021-01-26 Mosquito-repellent composition and application thereof

Country Status (1)

Country Link
CN (1) CN112891257B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1548028A (en) * 2003-05-13 2004-11-24 上海家化联合股份有限公司 Mosquito-repellent toilet water
WO2007079822A1 (en) * 2005-12-22 2007-07-19 Merck Patent Gmbh Insect repellent mixture
CN102160556A (en) * 2010-02-23 2011-08-24 刘澜涛 Composite mosquito repelling lotion
CN109248100A (en) * 2018-10-25 2019-01-22 湖南雪天精细化工股份有限公司 A kind of mosquito repellent liquid and preparation method thereof
CN111249168A (en) * 2020-01-17 2020-06-09 广州润峰婴儿用品有限公司 Composition for preventing mosquito bites and preparation method thereof
CN111388372A (en) * 2020-04-08 2020-07-10 名臣健康用品股份有限公司 Plant composition for dispelling mosquitoes, cooling and relieving itching and preparation method thereof
CN111773140A (en) * 2020-07-21 2020-10-16 广州润峰婴儿用品有限公司 Plant essential oil composition and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1548028A (en) * 2003-05-13 2004-11-24 上海家化联合股份有限公司 Mosquito-repellent toilet water
WO2007079822A1 (en) * 2005-12-22 2007-07-19 Merck Patent Gmbh Insect repellent mixture
CN102160556A (en) * 2010-02-23 2011-08-24 刘澜涛 Composite mosquito repelling lotion
CN109248100A (en) * 2018-10-25 2019-01-22 湖南雪天精细化工股份有限公司 A kind of mosquito repellent liquid and preparation method thereof
CN111249168A (en) * 2020-01-17 2020-06-09 广州润峰婴儿用品有限公司 Composition for preventing mosquito bites and preparation method thereof
CN111388372A (en) * 2020-04-08 2020-07-10 名臣健康用品股份有限公司 Plant composition for dispelling mosquitoes, cooling and relieving itching and preparation method thereof
CN111773140A (en) * 2020-07-21 2020-10-16 广州润峰婴儿用品有限公司 Plant essential oil composition and application thereof

Also Published As

Publication number Publication date
CN112891257B (en) 2022-11-15

Similar Documents

Publication Publication Date Title
US4107328A (en) Antimicrobial compositions and methods for utilizing the same employing mixtures of amines
US4091090A (en) Potentiated anesthetics
US5013545A (en) Aqueous gels containing topical medicaments
EP0060553B1 (en) Preparation for treating outer skin wounds and process for manufacturing said preparation
US6811789B2 (en) Fragrant composition having mosquito-repelling effect
US4224319A (en) Antiseptic composition for topical application to the skin
CN111773140B (en) Plant essential oil composition and application thereof
JPH06509564A (en) antibacterial mixture
JPS6126761B2 (en)
US5098717A (en) Method of treatment for pruritus
WO2021217324A1 (en) Disinfectant composition, preparation method therefor, and use thereof
WO2020176697A1 (en) Insect repelling compositions and methods of manufacture thereof
CN112370379A (en) Plant essential oil spray for repelling mosquitoes, relieving itching and inhibiting bacteria and application
EP2081428B1 (en) Antipediculosis composition having a lice-suffocating activity
CN101780020B (en) Cool and refreshing toilet water capable of relieving itching and expelling mosquito
CN112807259B (en) Safe and nontoxic mosquito-repellent composition and preparation method and application thereof
CN112891257B (en) Mosquito-repellent composition and application thereof
CN112891285A (en) Mite removing composition, shower gel containing mite removing composition and preparation method of shower gel
KR101788179B1 (en) Low irritation skin external application composition with an improved antiseptic ability
CN112826768A (en) Oil-control mite-removal shampoo and preparation method thereof
CN113476316A (en) High-safety mosquito repelling gel and preparation method thereof
RU2118152C1 (en) Cosmetic cream for prophylaxis of skin mycosis "rada-plus"
JP3333428B2 (en) External preparation for skin
JP2010527349A (en) Mosquito repellent
CN114569516B (en) Itching relieving and inflammation diminishing composition, itching relieving and inflammation diminishing wet tissue and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant